Hirtle Callaghan & Co LLC
- SEC CIK
- 0001360710
- Latest filing
- Aug 14, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Hirtle Callaghan & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −2,042−100.0% | Sold out | Holders |
| Q1 2026 | 2,042 | $1.00M | <0.1% | −61−2.9% | Reduced | Holders |
| Q4 2025 | 2,103 | $1.22M | <0.1% | +25+1.2% | Added | Holders |
| Q3 2025 | 2,078 | $1.01M | <0.1% | −16−0.8% | Reduced | Holders |
| Q2 2025 | 2,094 | $849.0K | <0.1% | +94+4.7% | Added | Holders |
| Q1 2025 | 2,000 | $995.2K | <0.1% | +2,000 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −685−100.0% | Sold out | Holders |
| Q4 2023 | 685 | $363.6K | <0.1% | +685 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −1,106−100.0% | Sold out | Holders |
| Q1 2023 | 1,106 | $637.5K | <0.1% | −8,059−87.9% | Reduced | Holders |
| Q4 2022 | 9,165 | $5.05M | 0.3% | +4,520+97.3% | Added | Holders |
| Q3 2022 | 4,645 | $2.36M | 0.2% | −2,771−37.4% | Reduced | Holders |
| Q2 2022 | 7,416 | $4.03M | 0.2% | −416−5.3% | Reduced | Holders |
| Q1 2022 | 7,832 | $4.63M | 0.2% | +5,722+271.2% | Added | Holders |
| Q4 2021 | 2,110 | $1.41M | 0.1% | +2,110 | New | Holders |